Company Filing History:
Years Active: 2010
Title: The Innovative Contributions of Stefan Vodny
Introduction
Stefan Vodny is a notable inventor based in Bratislava, Slovakia. He has made significant contributions to the field of pharmaceuticals, particularly in the development of methods for manufacturing important compounds. His work has implications for the production of medications that are vital for various health conditions.
Latest Patents
Stefan Vodny holds a patent for a method for manufacturing crystalline form I of clopidogrel hydrogen sulphate. This method involves the separation of the compound from a solution of clopidogrel in the form of the free base or salt, utilizing a solvent selected from a range of primary, secondary, or tertiary C1-C5 alcohols, their esters with C1-C4 carboxylic acids, or mixtures thereof. This innovation is crucial for the pharmaceutical industry, as it enhances the production process of clopidogrel hydrogen sulphate.
Career Highlights
Stefan Vodny is currently employed at Zentiva, a prominent pharmaceutical company. His role at Zentiva allows him to apply his expertise in the field of drug manufacturing and development. His innovative approach has contributed to the company's reputation for producing high-quality pharmaceutical products.
Collaborations
Stefan has collaborated with several professionals in his field, including Miroslav Veverka and Eva Veverkova. These collaborations have fostered a productive environment for innovation and have led to advancements in pharmaceutical manufacturing techniques.
Conclusion
Stefan Vodny's contributions to the field of pharmaceuticals through his innovative patent and work at Zentiva highlight the importance of research and development in improving medication production. His efforts continue to impact the industry positively.